A FIRST-IN-HUMAN, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION PHASE I CLINICAL STUDY OF SINGLE-AGENT RO7172508 IN PATIENTS WITH LOLALLY ADVANCED AND/OR METASTATIC CEA-POSITIVE SOLID TUMORS
2017-003834-10TUMORES SÓLIDOS POSITIVOS AVANZADOSFundación Jiménez DíazInvestigador: MORENO GARCIA VICTOR